Metabolic analysis involves ongoing biological
pathways and can be more distal than proteomic/genomic approaches
to in vitro diagnostics (IVD). However, point-of-care (POC)
metabolic analysis needs special designed materials to detect
target biomarkers of low concentration in complex
biosystems.